The Cell Therapy Stream examines advances in CMC development and manufacturing for in vivo CAR-T, gene therapies, and cell therapies, bringing together specialists in process development, analytical development, and manufacturing to address common challenges in advanced therapy production. Part One focuses on emerging approaches for in vivo CAR-T, exploring delivery technologies, process development, analytical strategies, and CMC considerations for engineering therapeutic cells directly within the patient. The Gene Therapy CMC conference focuses on vector process development, analytical characterization, product quality, scale-up, and commercial readiness. The Cell Therapy CMC and Manufacturing conference highlights cost-effective process development, automation, and scalable manufacturing across autologous, allogeneic, and other ex vivo cell therapies.

Conferences Include: